113 related articles for article (PubMed ID: 35848736)
1. Rectosigmoid Cancer-Rectal Cancer or Sigmoid Cancer?
Hui C; Baclay R; Liu K; Sandhu N; Loo P; von Eyben R; Chen C; Sheth V; Vitzthum L; Chang D; Pollom E
Am J Clin Oncol; 2022 Aug; 45(8):333-337. PubMed ID: 35848736
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the sigmoid take-off with other definitions of the rectosigmoid junction: A retrospective comparative cohort analysis.
Li F; Wang B; Lu S; Wang Y; Sun T; Wang H; Zhou X; Fu W
Int J Surg; 2020 Aug; 80():168-174. PubMed ID: 32650119
[TBL] [Abstract][Full Text] [Related]
3. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
[No Abstract] [Full Text] [Related]
4. Sigmoid take-off in rectosigmoid cancer as a landmark identifying benefit from neoadjuvant chemoradiation: A retrospective comparative cohort study.
Li F; Qu R; Meng Y; Li N; Chen M; Wang H; Zhou X; Fu W
Asian J Surg; 2023 Oct; 46(10):4330-4336. PubMed ID: 37803809
[TBL] [Abstract][Full Text] [Related]
5. Local recurrence after curative anterior resection with principally blunt dissection for carcinoma of the rectum and rectosigmoid.
Polglase AL; McMurrick PJ; Tremayne AB; Bhathal PS
Dis Colon Rectum; 2001 Jul; 44(7):947-54. PubMed ID: 11496074
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of short-term efficacy and perioperative safety between neoadjuvant therapy and total neoadjuvant therapy in patients with locally advanced rectal cancer].
Zhai ZW; Zhang KN; Wang C; Han JG; Ma HC; Wei GH; Yang Y; Wang ZJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):274-280. PubMed ID: 32192307
[No Abstract] [Full Text] [Related]
7. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
[No Abstract] [Full Text] [Related]
8. Rectal NETs and rectosigmoid junction NETs may need to be treated differently.
Cai W; Ge W; Hu H; Mao J
Cancer Med; 2020 Feb; 9(3):971-979. PubMed ID: 31840409
[TBL] [Abstract][Full Text] [Related]
9. Oncological outcome of carcinomas in the rectosigmoid junction compared to the upper rectum or sigmoid colon - A retrospective cohort study.
Falch C; Mueller S; Braun M; Gani C; Fend F; Koenigsrainer A; Kirschniak A
Eur J Surg Oncol; 2019 Nov; 45(11):2037-2044. PubMed ID: 31239157
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant chemoradiation improves oncologic outcomes in low and mid clinical T3N0 rectal cancers.
Lavryk OA; Manilich E; Valente MA; Miriam A; Gorgun E; Kalady MF; Shawki S; Delaney CP; Steele SR
Int J Colorectal Dis; 2020 Jan; 35(1):77-84. PubMed ID: 31776698
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant-intensified treatment for rectal cancer: time to change?
Musio D; De Felice F; Bulzonetti N; Guarnaccia R; Caiazzo R; Bangrazi C; Raffetto N; Tombolini V
World J Gastroenterol; 2013 May; 19(20):3052-61. PubMed ID: 23716984
[TBL] [Abstract][Full Text] [Related]
12. Intramural and mesorectal distal spread detected by whole-mount sections in the determination of optimal distal resection margin in patients undergoing surgery for rectosigmoid or rectal cancer without preoperative therapy.
Shimada Y; Takii Y; Maruyama S; Ohta T
Dis Colon Rectum; 2011 Dec; 54(12):1510-20. PubMed ID: 22067179
[TBL] [Abstract][Full Text] [Related]
13. Rectosigmoid tumours: should we continue sitting on the fence?
Bagla N; Schofield JB
Colorectal Dis; 2007 Sep; 9(7):606-8. PubMed ID: 17824977
[TBL] [Abstract][Full Text] [Related]
14. A systematic review and meta-analysis comparing surgical and oncological outcomes of upper rectal, rectosigmoid and sigmoid tumours.
Morarasu S; O'Brien L; Clancy C; Dietrich D; Maurer CA; Frasson M; Garcia-Granero E; Martin ST
Eur J Surg Oncol; 2021 Sep; 47(9):2421-2428. PubMed ID: 34016500
[TBL] [Abstract][Full Text] [Related]
15. Different patterns of lymphatic spread of sigmoid, rectosigmoid, and rectal cancers.
Park IJ; Choi GS; Lim KH; Kang BM; Jun SH
Ann Surg Oncol; 2008 Dec; 15(12):3478-83. PubMed ID: 18830668
[TBL] [Abstract][Full Text] [Related]
16. [Short-term outcome of programmed cell death protein1 (PD-1) antibody combined with total neoadjuvant chemoradiotherapy in the treatment of locally advanced middle-low rectal cancer with high risk factors].
Li YJ; Zhang L; Dong QS; Cai Y; Zhang YZ; Wang L; Yao YF; Zhang XY; Li ZW; Li YH; Sun YS; Wang WH; Wu AW
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Nov; 24(11):998-1007. PubMed ID: 34823301
[No Abstract] [Full Text] [Related]
17. [Efficacy analysis of neoadjuvant chemoradiotherapy combined with total pelvic exenteration in the treatment of primary T4b rectal cancer].
Wu T; Wen L; Zhang J; Wu Y; Jiang Y; Chen G; Wang X; Huang S; Wan Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):59-65. PubMed ID: 30703795
[TBL] [Abstract][Full Text] [Related]
18. MRI identified prognostic features of tumors in distal sigmoid, rectosigmoid, and upper rectum: treatment with radiotherapy and chemotherapy.
Burton S; Brown G; Daniels I; Norman A; Swift I; Abulafi M; Wotherspoon A; Tait D
Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):445-51. PubMed ID: 16690432
[TBL] [Abstract][Full Text] [Related]
19. [Effects of neoadjuvant chemoradiotherapy on the rates of sphincter preserving surgery in lower rectal cancer and analysis of their prognostic factors].
Wang XJ; Chi P; Lin HM; Lu XR; Huang Y; Xu ZB; Huang SH; Sun YW; Ye DX
Zhonghua Wai Ke Za Zhi; 2016 Jun; 54(6):419-423. PubMed ID: 27938574
[No Abstract] [Full Text] [Related]
20. The sigmoid take-off as a landmark to distinguish rectal from sigmoid tumours on MRI: Reproducibility, pitfalls and potential impact on treatment stratification.
Bogveradze N; Lambregts DMJ; El Khababi N; Dresen RC; Maas M; Kusters M; Tanis PJ; Beets-Tan RGH;
Eur J Surg Oncol; 2022 Jan; 48(1):237-244. PubMed ID: 34583878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
